Skip to main content
Erschienen in: Clinical Orthopaedics and Related Research® 12/2011

01.12.2011 | Clinical Research

Are Bone and Serum Cefazolin Concentrations Adequate for Antimicrobial Prophylaxis?

verfasst von: Koji Yamada, MD, Kunihiro Matsumoto, PhD, Fumiaki Tokimura, MD, Hiroshi Okazaki, MD, PhD, Sakae Tanaka, MD, PhD

Erschienen in: Clinical Orthopaedics and Related Research® | Ausgabe 12/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Antimicrobial prophylaxis is considered beneficial for preventing surgical-site infections in clean orthopaedic surgery. However, whether tissue concentrations of cefazolin achieve the minimum inhibitory concentration for the targeted contaminants have yet to be clarified.

Questions/purposes

We asked whether 2 g of cefazolin would enable effective serum and bone concentrations relative to the current minimum inhibitory concentration for cefazolin-resistant coagulase-negative Staphylococci and methicillin-sensitive Staphylococcus aureus.

Patients and Methods

We enrolled 43 patients (THA, n = 16; TKA, n = 27) scheduled for primary THAs and primary TKAs. Subjects were given 2 g of cefazolin intravenously before incision. One blood sample and two bone samples were collected from each subject before tourniquet deflation before any additional dose. All samples were assayed at the same laboratory. Minimum inhibitory concentration values were defined based on nationwide surveys.

Results

Mean (± standard deviation) serum concentration was 170.3 ± 51.3 μg/mL (range, 99.3–370.3 μg/mL). Mean bone concentration was 32.3 ± 15.2 μg/g (range, 11.4–70.0 μg/g) in THA, and 16.0 ± 10.4 μg/g (range, 6.3–46.3 μg/g) in TKA. All serum and bone concentrations exceeded the minimum inhibitory concentration for methicillin-sensitive S. aureus, but some serum levels were marginal and no bone levels exceeded the minimum inhibitory concentration for cefazolin-resistant coagulase-negative Staphylococcus.

Conclusions

Our data suggest intravenous administration of 2 g of cefazolin achieves the minimum inhibitory concentration for methicillin-sensitive S. aureus in serum and bone, but not the minimum inhibitory concentration for cefazolin-resistant coagulase-negative Staphylococcus in bone, resulting in a potential risk of deep surgical site infections in THAs and TKAs.
Literatur
1.
Zurück zum Zitat Bannister GC, Auchincloss JM, Johnson DP, Newman JH. The timing of tourniquet application in relation to prophylactic antibiotic administration. J Bone Joint Surg Br. 1988;70:322–324.PubMed Bannister GC, Auchincloss JM, Johnson DP, Newman JH. The timing of tourniquet application in relation to prophylactic antibiotic administration. J Bone Joint Surg Br. 1988;70:322–324.PubMed
2.
Zurück zum Zitat Bernard L, Sadowski C, Monin D, Stern R, Wyssa B, Rohner P, Lew D, Hoffmeyer P. The value of bacterial culture during clean orthopedic surgery: a prospective study of 1,036 patients. Infect Control Hosp Epidemiol. 2004;25:512–514.PubMedCrossRef Bernard L, Sadowski C, Monin D, Stern R, Wyssa B, Rohner P, Lew D, Hoffmeyer P. The value of bacterial culture during clean orthopedic surgery: a prospective study of 1,036 patients. Infect Control Hosp Epidemiol. 2004;25:512–514.PubMedCrossRef
3.
Zurück zum Zitat Bratzler DW, Houck PM; Surgical Infection Prevention Guidelines Writers Workgroup; American Academy of Orthopaedic Surgeons; American Association of Critical Care Nurses; American Association of Nurse Anesthetists; American College of Surgeons; American College of Osteopathic Surgeons; American Geriatrics Society; American Society of Anesthesiologists; American Society of Colon and Rectal Surgeons; American Society of Health-System Pharmacists; American Society of PeriAnesthesia Nurses; Ascension Health; Association of periOperative Registered Nurses; Association for Professionals in Infection Control and Epidemiology; Infectious Diseases Society of America; Medical Letter; Premier; Society for Healthcare Epidemiology of America; Society of Thoracic Surgeons; Surgical Infection Society. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis. 2004;38:1706–1715.PubMedCrossRef Bratzler DW, Houck PM; Surgical Infection Prevention Guidelines Writers Workgroup; American Academy of Orthopaedic Surgeons; American Association of Critical Care Nurses; American Association of Nurse Anesthetists; American College of Surgeons; American College of Osteopathic Surgeons; American Geriatrics Society; American Society of Anesthesiologists; American Society of Colon and Rectal Surgeons; American Society of Health-System Pharmacists; American Society of PeriAnesthesia Nurses; Ascension Health; Association of periOperative Registered Nurses; Association for Professionals in Infection Control and Epidemiology; Infectious Diseases Society of America; Medical Letter; Premier; Society for Healthcare Epidemiology of America; Society of Thoracic Surgeons; Surgical Infection Society. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis. 2004;38:1706–1715.PubMedCrossRef
4.
Zurück zum Zitat Chang Y, Shih HN, Chen DW, Lee MS, Ueng SW, Hsieh PH. The concentration of antibiotic in fresh-frozen bone graft. J Bone Joint Surg Br. 2010;92:1471–1474.PubMedCrossRef Chang Y, Shih HN, Chen DW, Lee MS, Ueng SW, Hsieh PH. The concentration of antibiotic in fresh-frozen bone graft. J Bone Joint Surg Br. 2010;92:1471–1474.PubMedCrossRef
5.
Zurück zum Zitat Chin NX, Neu NM, Neu HC. Activity of cephalosporins against coagulase-negative staphylococci. Diagn Microbiol Infect Dis. 1990;13:67–69.PubMedCrossRef Chin NX, Neu NM, Neu HC. Activity of cephalosporins against coagulase-negative staphylococci. Diagn Microbiol Infect Dis. 1990;13:67–69.PubMedCrossRef
6.
Zurück zum Zitat Cunha BA, Gossling HR, Pasternak HS, Nightingale CH, Quintiliani R. The penetration characteristics of cefazolin, cephalothin, and cephradine into bone in patients undergoing total hip replacement. J Bone Joint Surg Am. 1977;59:856–859.PubMed Cunha BA, Gossling HR, Pasternak HS, Nightingale CH, Quintiliani R. The penetration characteristics of cefazolin, cephalothin, and cephradine into bone in patients undergoing total hip replacement. J Bone Joint Surg Am. 1977;59:856–859.PubMed
7.
Zurück zum Zitat Dalstrom DJ, Venkatarayappa I, Manternach AL, Palcic MS, Heyse BA, Prayson MJ. Time-dependent contamination of opened sterile operating-room trays. J Bone Joint Surg Am. 2008;90:1022–1025.PubMedCrossRef Dalstrom DJ, Venkatarayappa I, Manternach AL, Palcic MS, Heyse BA, Prayson MJ. Time-dependent contamination of opened sterile operating-room trays. J Bone Joint Surg Am. 2008;90:1022–1025.PubMedCrossRef
8.
Zurück zum Zitat Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004;350:1422–1429.PubMedCrossRef Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004;350:1422–1429.PubMedCrossRef
9.
Zurück zum Zitat Fletcher N, Sofianos D, Berkes MB, Obremskey WT. Prevention of perioperative infection. J Bone Joint Surg Am. 2007;89:1605–1618.PubMedCrossRef Fletcher N, Sofianos D, Berkes MB, Obremskey WT. Prevention of perioperative infection. J Bone Joint Surg Am. 2007;89:1605–1618.PubMedCrossRef
10.
Zurück zum Zitat Forse RA, Karam B, MacLean LD, Christou NV. Antibiotic prophylaxis for surgery in morbidly obese patients. Surgery. 1989;106:750–756; discussion 756–757.PubMed Forse RA, Karam B, MacLean LD, Christou NV. Antibiotic prophylaxis for surgery in morbidly obese patients. Surgery. 1989;106:750–756; discussion 756–757.PubMed
11.
Zurück zum Zitat Friedman RJ, Friedrich LV, White RL, Kays MB, Brundage DM, Graham J. Antibiotic prophylaxis and tourniquet inflation in total knee arthroplasty. Clin Orthop Relat Res. 1990;260:17–23.PubMed Friedman RJ, Friedrich LV, White RL, Kays MB, Brundage DM, Graham J. Antibiotic prophylaxis and tourniquet inflation in total knee arthroplasty. Clin Orthop Relat Res. 1990;260:17–23.PubMed
12.
Zurück zum Zitat Friedrich LV, White RL, Brundage DM, Kays MB, Friedman RJ. The effect of tourniquet inflation on cefazolin tissue penetration during total knee arthroplasty. Pharmacotherapy. 1990;10:373–377.PubMed Friedrich LV, White RL, Brundage DM, Kays MB, Friedman RJ. The effect of tourniquet inflation on cefazolin tissue penetration during total knee arthroplasty. Pharmacotherapy. 1990;10:373–377.PubMed
13.
Zurück zum Zitat Fujimura T, Yoshida I, Itoh Y, Tachibana M, Kaku M, Kanemitsu K, Takahashi C, Shiotani J, Ono Y, Baba H, Matsuo S, Asari S, Matsuoka K, Kusano N, Nose M, Saikawa T, Hiramatsu K, Kohno S, Hirakata Y, Yamane N, Nakasone I, Yamano Y. [Antimicrobial susceptibility of clinical isolates of aerobic Gram-positive cocci and anaerobic bacteria in 2004][in Japanese]. Jpn J Chemother. 2008;56:543–561. Fujimura T, Yoshida I, Itoh Y, Tachibana M, Kaku M, Kanemitsu K, Takahashi C, Shiotani J, Ono Y, Baba H, Matsuo S, Asari S, Matsuoka K, Kusano N, Nose M, Saikawa T, Hiramatsu K, Kohno S, Hirakata Y, Yamane N, Nakasone I, Yamano Y. [Antimicrobial susceptibility of clinical isolates of aerobic Gram-positive cocci and anaerobic bacteria in 2004][in Japanese]. Jpn J Chemother. 2008;56:543–561.
14.
Zurück zum Zitat Garza-Gonzalez E, Morfin-Otero R, Llaca-Diaz JM, Rodriguez-Noriega E. Staphylococcal cassette chromosome mec (SCC mec) in methicillin-resistant coagulase-negative staphylococci: a review and the experience in a tertiary-care setting. Epidemiol Infect. 2010;138:645–654.PubMedCrossRef Garza-Gonzalez E, Morfin-Otero R, Llaca-Diaz JM, Rodriguez-Noriega E. Staphylococcal cassette chromosome mec (SCC mec) in methicillin-resistant coagulase-negative staphylococci: a review and the experience in a tertiary-care setting. Epidemiol Infect. 2010;138:645–654.PubMedCrossRef
15.
Zurück zum Zitat Irie S, Terakawa M, Ishibashi K, Tabata K, Suzuki S, Yokota Y. [Pharmacokinetic study of a parenteral cephalosporin, cefazolin in healthy volunteers given Cefamezin® -infusion 1-g kit][in Japanese]. Kagakuryouhou no Ryouiki. 1999;15:766–774. Irie S, Terakawa M, Ishibashi K, Tabata K, Suzuki S, Yokota Y. [Pharmacokinetic study of a parenteral cephalosporin, cefazolin in healthy volunteers given Cefamezin® -infusion 1-g kit][in Japanese]. Kagakuryouhou no Ryouiki. 1999;15:766–774.
16.
Zurück zum Zitat Johnson DP. Antibiotic prophylaxis with cefuroxime in arthroplasty of the knee. J Bone Joint Surg Br 1987;69:787–789.PubMed Johnson DP. Antibiotic prophylaxis with cefuroxime in arthroplasty of the knee. J Bone Joint Surg Br 1987;69:787–789.PubMed
17.
Zurück zum Zitat Kimura Y, Nagano K, Higashiyama I, Jinushi Y, Sasaki S, Yoshida I. [Surveillance of susceptibility of clinical isolates of various bacterial species to antibacterial agents -No.1 against Gram-positive cocci isolated in 1994][in Japanese]. Jpn J Chemother. 1996;44:595–609. Kimura Y, Nagano K, Higashiyama I, Jinushi Y, Sasaki S, Yoshida I. [Surveillance of susceptibility of clinical isolates of various bacterial species to antibacterial agents -No.1 against Gram-positive cocci isolated in 1994][in Japanese]. Jpn J Chemother. 1996;44:595–609.
18.
Zurück zum Zitat Kimura Y, Yoshida I, Higashiyama I, Nagano K, Sasaki S. [Surveillance of susceptibility of clinical isolates of various bacterial species to antibacterial agents -No.1 against Gram-positive cocci isolated in 1996][in Japanese]. Jpn J Chemother. 1998;46:324–342. Kimura Y, Yoshida I, Higashiyama I, Nagano K, Sasaki S. [Surveillance of susceptibility of clinical isolates of various bacterial species to antibacterial agents -No.1 against Gram-positive cocci isolated in 1996][in Japanese]. Jpn J Chemother. 1998;46:324–342.
19.
Zurück zum Zitat Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999;20:250–278; quiz 279–280.PubMedCrossRef Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999;20:250–278; quiz 279–280.PubMedCrossRef
20.
Zurück zum Zitat Moran E, Masters S, Berendt AR, McLardy-Smith P, Byren I, Atkins BL. Guiding empirical antibiotic therapy in orthopaedics: the microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention. J Infect. 2007;55:1–7.PubMedCrossRef Moran E, Masters S, Berendt AR, McLardy-Smith P, Byren I, Atkins BL. Guiding empirical antibiotic therapy in orthopaedics: the microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention. J Infect. 2007;55:1–7.PubMedCrossRef
21.
Zurück zum Zitat Nickinson RS, Board TN, Gambhir AK, Porter ML, Kay PR. The microbiology of the infected knee arthroplasty. Int Orthop. 2010;34:505–510.PubMedCrossRef Nickinson RS, Board TN, Gambhir AK, Porter ML, Kay PR. The microbiology of the infected knee arthroplasty. Int Orthop. 2010;34:505–510.PubMedCrossRef
22.
Zurück zum Zitat Oliveira AD, d’Azevedo PA, de Sousa LB, Viana-Niero C, Francisco W, Lottenberg C, Martino MD, Hofling-Lima AL. Laboratory detection methods for methicillin resistance in coagulase negative Staphylococcus isolated from ophthalmic infections. Arq Bras Oftalmol. 2007;70:667–675.PubMedCrossRef Oliveira AD, d’Azevedo PA, de Sousa LB, Viana-Niero C, Francisco W, Lottenberg C, Martino MD, Hofling-Lima AL. Laboratory detection methods for methicillin resistance in coagulase negative Staphylococcus isolated from ophthalmic infections. Arq Bras Oftalmol. 2007;70:667–675.PubMedCrossRef
23.
Zurück zum Zitat Osmon DR. Antimicrobial resistance: guidelines for the practicing orthopaedic surgeon. Instr Course Lect. 2002;51:527–537.PubMed Osmon DR. Antimicrobial resistance: guidelines for the practicing orthopaedic surgeon. Instr Course Lect. 2002;51:527–537.PubMed
24.
Zurück zum Zitat Ostrander RV, Botte MJ, Brage ME. Efficacy of surgical preparation solutions in foot and ankle surgery. J Bone Joint Surg Am. 2005;87:980–985.PubMedCrossRef Ostrander RV, Botte MJ, Brage ME. Efficacy of surgical preparation solutions in foot and ankle surgery. J Bone Joint Surg Am. 2005;87:980–985.PubMedCrossRef
25.
Zurück zum Zitat Prokuski L. Prophylactic antibiotics in orthopaedic surgery. J Am Acad Orthop Surg. 2008;16:283–293.PubMed Prokuski L. Prophylactic antibiotics in orthopaedic surgery. J Am Acad Orthop Surg. 2008;16:283–293.PubMed
26.
Zurück zum Zitat Quintiliani R, Nightingale C. Principles of antibiotic usage. Clin Orthop Relat Res. 1984;190:31–35.PubMed Quintiliani R, Nightingale C. Principles of antibiotic usage. Clin Orthop Relat Res. 1984;190:31–35.PubMed
27.
Zurück zum Zitat Raad I, Alrahwan A, Rolston K. Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin Infect Dis. 1998;26:1182–1187.PubMedCrossRef Raad I, Alrahwan A, Rolston K. Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin Infect Dis. 1998;26:1182–1187.PubMedCrossRef
28.
Zurück zum Zitat Rafiq I, Gambhir AK, Wroblewski BM, Kay PR. The microbiology of infected hip arthroplasty. Int Orthop. 2006;30:532–535.PubMedCrossRef Rafiq I, Gambhir AK, Wroblewski BM, Kay PR. The microbiology of infected hip arthroplasty. Int Orthop. 2006;30:532–535.PubMedCrossRef
29.
Zurück zum Zitat Saegeman V, Lismont D, Verduyckt B, Ectors N, Stuyck J, Verhaegen J. Antimicrobial susceptibility of coagulase-negative staphylococci on tissue allografts and isolates from orthopedic patients. J Orthop Res. 2007;25:501–507.PubMedCrossRef Saegeman V, Lismont D, Verduyckt B, Ectors N, Stuyck J, Verhaegen J. Antimicrobial susceptibility of coagulase-negative staphylococci on tissue allografts and isolates from orthopedic patients. J Orthop Res. 2007;25:501–507.PubMedCrossRef
30.
Zurück zum Zitat Savitz SI, Savitz MH, Goldstein HB, Mouracade CT, Malangone S. Topical irrigation with polymyxin and bacitracin for spinal surgery. Surg Neurol. 1998;50:208–212.PubMedCrossRef Savitz SI, Savitz MH, Goldstein HB, Mouracade CT, Malangone S. Topical irrigation with polymyxin and bacitracin for spinal surgery. Surg Neurol. 1998;50:208–212.PubMedCrossRef
31.
Zurück zum Zitat Schurman DJ, Hirshman HP, Kajiyama G, Moser K, Burton DS. Cefazolin concentrations in bone and synovial fluid. J Bone Joint Surg Am. 1978;60:359–362.PubMed Schurman DJ, Hirshman HP, Kajiyama G, Moser K, Burton DS. Cefazolin concentrations in bone and synovial fluid. J Bone Joint Surg Am. 1978;60:359–362.PubMed
32.
Zurück zum Zitat Sørensen TS, Colding H, Schroeder E, Rosdahl VT. The penetration of cefazolin, erythromycin and methicillin into human bone tissue. Acta Orthop Scand. 1978;49:549–553.PubMedCrossRef Sørensen TS, Colding H, Schroeder E, Rosdahl VT. The penetration of cefazolin, erythromycin and methicillin into human bone tissue. Acta Orthop Scand. 1978;49:549–553.PubMedCrossRef
33.
Zurück zum Zitat Whitehouse JD, Friedman ND, Kirkland KB, Richardson WJ, Sexton DJ. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol. 2002;23:183–189.PubMedCrossRef Whitehouse JD, Friedman ND, Kirkland KB, Richardson WJ, Sexton DJ. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol. 2002;23:183–189.PubMedCrossRef
34.
Zurück zum Zitat Wikler MA, Cockerill FR, Craig WA, Dudley MN, Eliopoulos GM, Hecht DW, Hindler JF, Low DE, Sheehan DJ, Tenover FC, Turnidge JD, Weinstein MP, Zimmer BL, Ferraro MJ, Swenson JM. Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2005. Wikler MA, Cockerill FR, Craig WA, Dudley MN, Eliopoulos GM, Hecht DW, Hindler JF, Low DE, Sheehan DJ, Tenover FC, Turnidge JD, Weinstein MP, Zimmer BL, Ferraro MJ, Swenson JM. Performance Standards for Antimicrobial Susceptibility Testing; Fifteenth Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2005.
35.
Zurück zum Zitat Williams DN, Gustilo RB, Beverly R, Kind AC. Bone and serum concentrations of five cephalosporin drugs: relevance to prophylaxis and treatment in orthopedic surgery. Clin Orthop Relat Res. 1983;179:253–265.PubMedCrossRef Williams DN, Gustilo RB, Beverly R, Kind AC. Bone and serum concentrations of five cephalosporin drugs: relevance to prophylaxis and treatment in orthopedic surgery. Clin Orthop Relat Res. 1983;179:253–265.PubMedCrossRef
37.
Zurück zum Zitat Yamada K, Okazaki H, Iga T, Nagai I, Tatsumi T, Touhara C, Sato W, Hasegawa J, Tanaka S, Matsudaira K, Nakamura K. [The surgical site is contaminated even in the clean orthopaedic surgery][in Japanese]. Nippon Seikeigeka Gakkai Zasshi. 2010;84:S707. Yamada K, Okazaki H, Iga T, Nagai I, Tatsumi T, Touhara C, Sato W, Hasegawa J, Tanaka S, Matsudaira K, Nakamura K. [The surgical site is contaminated even in the clean orthopaedic surgery][in Japanese]. Nippon Seikeigeka Gakkai Zasshi. 2010;84:S707.
38.
Zurück zum Zitat Yoshida I, Kimura Y, Higashiyama I, Sugimori G, Yamano Y. [Surveillance of susceptibility of clinical isolates of various bacterial species to antibacterial agents: antimicrobial activity against gram-positive cocci and anaerobic bacteria isolated in 2000][in Japanese]. Jpn J Chemother. 2003;51:179–208. Yoshida I, Kimura Y, Higashiyama I, Sugimori G, Yamano Y. [Surveillance of susceptibility of clinical isolates of various bacterial species to antibacterial agents: antimicrobial activity against gram-positive cocci and anaerobic bacteria isolated in 2000][in Japanese]. Jpn J Chemother. 2003;51:179–208.
Metadaten
Titel
Are Bone and Serum Cefazolin Concentrations Adequate for Antimicrobial Prophylaxis?
verfasst von
Koji Yamada, MD
Kunihiro Matsumoto, PhD
Fumiaki Tokimura, MD
Hiroshi Okazaki, MD, PhD
Sakae Tanaka, MD, PhD
Publikationsdatum
01.12.2011
Verlag
Springer-Verlag
Erschienen in
Clinical Orthopaedics and Related Research® / Ausgabe 12/2011
Print ISSN: 0009-921X
Elektronische ISSN: 1528-1132
DOI
https://doi.org/10.1007/s11999-011-2111-8

Weitere Artikel der Ausgabe 12/2011

Clinical Orthopaedics and Related Research® 12/2011 Zur Ausgabe

Symposium: Fractures of the Shoulder Girdle

Fractures of the Shoulder Girdle: Editorial Comment

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Knie-TEP: Kein Vorteil durch antibiotikahaltigen Knochenzement

29.05.2024 Periprothetische Infektionen Nachrichten

Zur Zementierung einer Knie-TEP wird in Deutschland zu über 98% Knochenzement verwendet, der mit einem Antibiotikum beladen ist. Ob er wirklich besser ist als Zement ohne Antibiotikum, kann laut Registerdaten bezweifelt werden.

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.